Scimar stands for "bringing Science to Market." We have an incredible breakthrough with the potential to end type 2 diabetes globally! But we have to get this science to market. The science is rooted in the discovery of hepatalin, a hormone that works alongside insulin. You need to have BOTH hormones to be healthy. Our products are designed to protect, measure, restore, or replace the action of hepatalin in your body. These products have been tested in the lab. We've shown they are safe and effective. But now we need to do clinical trials. This is an expensive process, and we are just a small family business based in Dauphin, Manitoba, so we are doing something very unique. We are now selling shares in the company directly to individuals. These are common voting shares, and are available to retail level investors through an SEC sanctioned process called "Regulation A." It is kind of like 'going public' but not quite. It is an exciting time for us, and if we prove this process works, then other small and medium sized Canadian companies can follow our lead and use Regulation A to raise capital.